On April 16, 2003, GYNECARE Worldwide, a division of Ethicon, Inc., a Johnson and Johnson company, announced an urgent global market withdrawal of GYNECARE INTERGEL, an adhesion prevention solution used in gynecological surgeries to reduce post-surgical adhesions. The product withdrawal is the result of reports of post-operative pain, non-infectious foreign body reactions and tissue adherence. Many patients had to endure repeat surgeries. Our firm represents a patient who suffered these injuries following a surgery in which GYNECARE INTERGEL was used.

If you or someone you know underwent gynecological surgery between 1998-2003 in which GYNECARE INTERGEL was used and suffered these or other post-surgical complications or injuries, you may be entitled to compensation. You can contact our firm for free legal advice. 510-849-1618 or email michael@schragbaum.com